SEC Filings TLDR
Stop wasting hours on dense SEC filings. Get AI-powered summaries of any SEC Filings in seconds. Understand key insights and risks, fast.
Currently we only process 8-K, 6-K, Schedule 13G. We will support more forms in the future.
Filter by Form Type:
2025-09-16TERNSCHEDULE 13GCommodore Capital LP and Affiliates File Schedule 13G for Terns Pharmaceuticals, Inc.MEDIUM
Commodore Capital LP, along with its affiliates Commodore Capital Master LP, Michael Kramarz, and Robert Egen Atkinson, have filed a Schedule 13G with the SEC, disclosing their beneficial ownership of 4,650,000 shares of Common Stock in Terns Pharmaceuticals, Inc. This represents approximately 5.3% of the total outstan...
2025-09-16TLPHSCHEDULE 13GSchedule 13G Filing by Laurence W. Lytton and Lytton-Kambara Foundation for TALPHERA, INC.MEDIUM
Laurence W. Lytton and the Lytton-Kambara Foundation have filed a Schedule 13G with the SEC, disclosing their beneficial ownership of shares in TALPHERA, INC. The filing indicates that both entities hold 3,636,364 shares each, representing 8.0% of the company's common stock. The shares are held with shared voting and d...
2025-09-16SUPXSCHEDULE 13GYong Rong (HK) Asset Management Limited's 8.3% Stake in Super X AI Technology LtdMEDIUM
Yong Rong (HK) Asset Management Limited, a Hong Kong private company, has reported an 8.3% beneficial ownership in Super X AI Technology Ltd. The filing, made under Rule 13d-1(c), indicates that Yong Rong (HK) Asset Management Limited owns 2,470,000 shares of common stock in Super X AI Technology Ltd. The shares are he...
2025-09-16SNCRSCHEDULE 13GMount Logan Capital Inc. Reports 7.5% Ownership in Synchronoss Technologies, Inc.MEDIUM
Mount Logan Capital Inc. has filed a Schedule 13G reporting a 7.5% ownership in Synchronoss Technologies, Inc. The filing indicates that Mount Logan Capital Inc. beneficially owns 866,788 shares of common stock. The shares were acquired through a business combination with 180 Degree Capital Corp., which closed on Septe...
2025-09-16MESOSCHEDULE 13GDr. William Gueck's Beneficial Ownership in Mesoblast LtdMEDIUM
Dr. William Gueck has filed a Schedule 13G indicating his beneficial ownership of 64,521,900 Ordinary Shares in Mesoblast Ltd, representing approximately 5.0% of the outstanding shares. This includes 525,000 Ordinary Shares held directly by Dr. Gueck and additional shares held through various trusts and entities where ...
2025-09-16OCTOSCHEDULE 13GSchedule 13G Filing for Eightco Holdings Inc. by CoinFund EntitiesMEDIUM
The Schedule 13G filing reports the beneficial ownership of Common Stock in Eightco Holdings Inc. by several entities associated with CoinFund. The filing includes CF Series DAT A LP, CoinFund Liquid Opportunities LP, Series F Liquid Opportunities LP, Series G Liquid Opportunities LP, and their respective general partn...
2025-09-16OCTOSCHEDULE 13GDiscovery Capital Management, LLC and Others File Schedule 13G for Eightco Holdings Inc.MEDIUM
Discovery Capital Management, LLC, Robert K. Citrone, and Discovery Global Opportunity Master Fund, Ltd. have filed a Schedule 13G with the SEC, disclosing their beneficial ownership of shares in Eightco Holdings Inc. The filing indicates that Discovery Capital Management, LLC and Robert K. Citrone each beneficially ow...
2025-09-16CAMPSCHEDULE 13GCoastlands Capital LP and Affiliates Report 9.99% Ownership in Camp4 Therapeutics CorpMEDIUM
Coastlands Capital LP, along with its affiliates Coastlands Capital Partners LP, Coastlands Capital GP LLC, Coastlands Capital LLC, and Matthew D. Perry, have reported a 9.99% ownership in Camp4 Therapeutics Corp. The ownership includes 4,886,722 shares of common stock, which represents 10.0% of the total outstanding s...
2025-09-16CSTMSCHEDULE 13GMillennium Management LLC and Affiliates File Schedule 13G for Constellium SEMEDIUM
Millennium Management LLC, Millennium Group Management LLC, and Israel A. Englander have filed a Schedule 13G with the SEC, disclosing their beneficial ownership of 7,453,770 ordinary shares of Constellium SE, representing approximately 5.3% of the total outstanding shares. The filing, made under Rule 13d-1(c), indicat...
2025-09-16SCORSCHEDULE 13GMount Logan Capital Inc. Files Schedule 13G for comScore, Inc.MEDIUM
Mount Logan Capital Inc. has filed a Schedule 13G with the SEC, disclosing its ownership of 400,451 shares of comScore, Inc. common stock, representing 8.0% of the outstanding shares. The filing indicates that Mount Logan Capital Inc. has shared voting and dispositive power over these shares. The filing also includes c...
2025-09-16CYCCSCHEDULE 13GFITTERS Diversified Berhad's Schedule 13G Filing for Bio Green Med Solution, Inc.MEDIUM
FITTERS Diversified Berhad, a Malaysian company, has filed a Schedule 13G with the SEC, disclosing its beneficial ownership of 699,158 shares of common stock in Bio Green Med Solution, Inc. This represents 19.99% of the total shares outstanding. The filing indicates that FITTERS Diversified Berhad has sole voting and d...
2025-09-15XFORSCHEDULE 13GBain Capital Life Sciences Entities' Ownership in X4 Pharmaceuticals, Inc.MEDIUM
Bain Capital Life Sciences Fund, L.P., Bain Capital Life Sciences Fund II, L.P., BCIP Life Sciences Associates, LP, BCLS II Investco, LP, BCLS I Investco, LP, and BCLS II Equity Opportunities, LP (collectively, the 'Reporting Persons') have filed a Schedule 13G to report their collective beneficial ownership of 9.99% o...
2025-09-15SLXNWSCHEDULE 13GOrca Capital AG's 6.2% Ownership in Silexion Therapeutics CorpMEDIUM
Orca Capital AG, a German entity, has filed a Schedule 13G with the SEC, disclosing a 6.2% ownership in Silexion Therapeutics Corp. The filing indicates that Orca Capital AG beneficially owns 131,250 ordinary shares of Silexion Therapeutics Corp, with sole voting and dispositive power over these shares. The shares are ...
2025-09-15SLXNWSCHEDULE 13GLincoln Alternative Strategies LLC's Ownership in Silexion Therapeutics Corp.MEDIUM
Lincoln Alternative Strategies LLC has filed a Schedule 13G with the SEC, disclosing its ownership of 131,250 ordinary shares of Silexion Therapeutics Corp., representing 6.18% of the total outstanding shares. The filing indicates that Lincoln Alternative Strategies LLC has sole voting and dispositive power over these ...
2025-09-15SERVSCHEDULE 13GKhosla Ventures' Ownership in Serve Robotics Inc.MEDIUM
The filing discloses the beneficial ownership of Common Stock in Serve Robotics Inc. by Khosla Ventures and related entities. As of the closing of the Issuer's merger on August 15, 2025, the Reporting Persons collectively own 4,801,324 shares of Common Stock, representing approximately 7.5% of the outstanding shares. T...
2025-09-15RAVESCHEDULE 13GBrian T. Bares and Bares Family Foundation, Inc. Schedule 13G Filing for Rave Restaurant Group, Inc.MEDIUM
Brian T. Bares and Bares Family Foundation, Inc. have filed a Schedule 13G with the SEC, disclosing their ownership of 1,388,715 shares of Rave Restaurant Group, Inc. common stock, representing 9.77% of the outstanding shares. The filing indicates that Brian T. Bares retains voting and dispositive power over the shares...
2025-09-15TO_BE_DECIDEDSCHEDULE 13GHarraden Circle Investments' Schedule 13G Filing for GSR III Acquisition Corp.MEDIUM
Harraden Circle Investments, LLC, along with several affiliated entities and Frederick V. Fortmiller, Jr., filed a Schedule 13G with the SEC, disclosing beneficial ownership of 5.26% of the Class A Common Stock of GSR III Acquisition Corp. The filing, made under Rule 13d-1(c), indicates that the shares are held for inv...
2025-09-15GMHSSCHEDULE 13GSchedule 13G Filing for Gamehaus Holdings Inc.MEDIUM
The Schedule 13G filing discloses that Beijing Zhiyi Venture Investment Centre (Limited Partnership), Beijing Zhiyi Capital Investment Management Co., Ltd., and Wenjiang Chen collectively beneficially own 3,296,068 Class A ordinary shares of Gamehaus Holdings Inc., representing 8.68% of the total Class A ordinary share...
2025-09-15TO_BE_DECIDEDSCHEDULE 13GHarraden Circle Investments and Affiliates File Schedule 13G for GSR III Acquisition Corp.MEDIUM
Harraden Circle Investments, LLC, along with its affiliates, has filed a Schedule 13G with the SEC, disclosing beneficial ownership of 5.26% of the Class A Common Stock of GSR III Acquisition Corp. The filing includes Harraden Circle Investors GP, LP, Harraden Circle Investors GP, LLC, Harraden Circle Investors, LP, Ha...
2025-09-15TO_BE_DECIDEDSCHEDULE 13GSchedule 13G Filing for GCL Global Holdings, Ltd by ATW EntitiesMEDIUM
The Schedule 13G filing reports the beneficial ownership of Ordinary Shares of GCL Global Holdings, Ltd by ATW Interactive Ventures, LLC, ATW Master Fund V LP, ATW Partners Opportunities Management, LLC, Kerry Propper, and Antonio Ruiz-Gimenez. The filing indicates that each entity and individual beneficially owns 13,5...
2025-09-15AACIWSCHEDULE 13GHarraden Circle Investments and Affiliates File Schedule 13G for Armada Acquisition Corp. IIMEDIUM
Harraden Circle Investments, LLC, along with its affiliates, has filed a Schedule 13G with the SEC, disclosing beneficial ownership of 1,206,800 shares of Class A Common Stock of Armada Acquisition Corp. II, representing 5.09% of the outstanding shares. The filing includes Harraden Circle Investors GP, LP, Harraden Cir...
2025-09-15TO_BE_DECIDEDSCHEDULE 13GATW Entities and Individuals Report 9.9% Ownership in GCL Global HoldingsMEDIUM
ATW Interactive Ventures, LLC, ATW Master Fund V LP, ATW Partners Opportunities Management, LLC, Kerry Propper, and Antonio Ruiz-Gimenez have jointly filed a Schedule 13G reporting a 9.9% beneficial ownership in GCL Global Holdings, Ltd. The ownership includes 13,539,366 ordinary shares, which are held directly by ATW ...
2025-09-12FGNXPSCHEDULE 13GSchedule 13G Filing for FG Nexus Inc. by Citadel Entities and Kenneth GriffinMEDIUM
The Schedule 13G filing reports the beneficial ownership of shares in FG Nexus Inc. by Citadel Advisors LLC, Citadel Advisors Holdings LP, Citadel GP LLC, Citadel Securities LLC, Citadel Securities Group LP, Citadel Securities GP LLC, and Kenneth Griffin. The filing indicates that Citadel Advisors LLC, Citadel Advisors...
2025-09-12FGNXSCHEDULE 13GCitadel Entities and Kenneth Griffin's Ownership in FG Nexus Inc.MEDIUM
The Schedule 13G filing discloses the ownership of common stock in FG Nexus Inc. by Citadel Advisors LLC, Citadel Advisors Holdings LP, Citadel GP LLC, Citadel Securities LLC, Citadel Securities Group LP, Citadel Securities GP LLC, and Kenneth Griffin. Collectively, these entities and individuals beneficially own 6.6% ...
2025-09-12YAASSCHEDULE 13GS.H.N. Financial Investments Ltd. Reports 9.99% Ownership in Youxin Technology LtdMEDIUM
S.H.N. Financial Investments Ltd. has filed a Schedule 13G with the SEC, reporting a 9.99% beneficial ownership in Youxin Technology Ltd. The filing details that S.H.N. Financial Investments Ltd. owns 4,638,200 Class A Ordinary Shares and Series A Warrants, which are subject to a 9.99% beneficial ownership limitation. ...